Editorial: Statins and Tissue Plasminogen Activator for Stroke: A Beneficial Combination?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|14|3|302-303

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.14, Iss.3, 2016-05, pp. : 302-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Combination Therapy Stroke Trial: Recombinant Tissue-Type Plasminogen Activator with/without Lubeluzole

By  

Cerebrovascular Diseases, Vol. 12, Iss. 3, 2001-10 ,pp. : 258-263

Karger

Access to resources Recommend Favorite

Centenarian Stroke Treated with Tissue-Type Plasminogen Activator

By  

Cerebrovascular Diseases, Vol. 13, Iss. 4, 2002-05 ,pp. : 285-287

Karger

Access to resources Recommend Favorite

Low-Dose Tissue Plasminogen Activator and Standard-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke in Asian Populations: A Review

By  

Cerebrovascular Diseases, Vol. 36, Iss. 3, 2013-10 ,pp. : 161-166

Karger

Access to resources Recommend Favorite

Intravenous Tissue Plasminogen Activator for an Ischemic Stroke with Occult Double Primary Cancer

By  

Case Reports in Neurology, Vol. 6, Iss. 3, 2014-10 ,pp. : 238-242

Karger

Access to resources Recommend Favorite

Unruptured Cerebral Aneurysm Detected after Intravenous Tissue Plasminogen Activator for Stroke

By  

Case Reports in Neurology, Vol. 1, Iss. 1, 2009-06 ,pp. : 20-23

Karger

Access to resources Recommend Favorite